Trials / Terminated
TerminatedNCT00167661
Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
- Status
- Terminated
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- University of Wisconsin, Madison · Academic / Other
- Sex
- All
- Age
- 18 Months – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether Campath-1H induction and the associated lymphocyte depletion will permit long-term rejection-free renal allograft survival in the absence of ongoing corticosteroid administration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Campath-1H | two intravenous 20mg/m2/doses, the first on the day of transplant and the second dose on day 1 post transplant |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2011-12-01
- Completion
- 2012-05-01
- First posted
- 2005-09-14
- Last updated
- 2020-09-21
- Results posted
- 2020-09-21
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT00167661. Inclusion in this directory is not an endorsement.